跳至主要内容
临床试验/IRCT20220524054983N1
IRCT20220524054983N1招募中3 期

Comparison of erythromycin and metoclopramide in the treatment of dysmotility in premature neonates

Karaj University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
8 months 至 no limit(—)
性别
All

入选标准

  • Neonates with gestational age of more than 32 weeks and postnatal ago of more than 2 weeks
  • Signs and symptoms of dysmotility; vomiting, abdominal distention, failure to defecate for more than 3 days
  • Absence of gastrointestinal anomaly; malrotation, intestinal atresia, necrotizing enterocolitis
  • Neonates with minimum weight of 800 grams and maximum of 1500 grams

排除标准

  • Drug reactions
  • Worsening of dysmotility signs and symptoms
  • Positive CRP in laboratory tests or any suspicion about gastrointestinal anomalies including intestinal malrotation, necrotizing enterocolitis and intestinal atresia
  • The impossibility of assessing the outcome due to transfer to another center or the loss of the infant.
  • Dissatisfaction with participation in the study

研究者

发起方
Karaj University of Medical Sciences

相似试验